Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Verizon
VZ
|
+$92M |
| 2 |
VRN
Veren
VRN
|
+$46M |
| 3 |
Perrigo
PRGO
|
+$25.1M |
| 4 |
VER
VEREIT, Inc.
VER
|
+$7.68M |
| 5 |
Liberty Global Class C
LBTYK
|
+$6.67M |
Top Sells
| 1 |
Apple
AAPL
|
+$51.6M |
| 2 |
COLE
COLE REAL ESTATE INVESTMENTS, INC COM
COLE
|
+$43.4M |
| 3 |
Exxon Mobil
XOM
|
+$42.4M |
| 4 |
Microsoft
MSFT
|
+$29.9M |
| 5 |
GE Aerospace
GE
|
+$26.8M |
Sector Composition
| 1 | Healthcare | 13.36% |
| 2 | Technology | 13.11% |
| 3 | Energy | 11.79% |
| 4 | Industrials | 11.1% |
| 5 | Consumer Staples | 10.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
VIVS
2001
VivoSim Labs, Inc. Common Stock
VIVS
$10.9M
| $626K | ﹤0.01% |
342
+66
| +24% | +$121K |
|
|
UHT
2002
Universal Health Realty Income Trust
UHT
$575M
| $625K | ﹤0.01% |
14,800
+3,000
| +25% | +$127K |
|
|
STNR
2003
DELISTED
STEINER LEISURE LTD
STNR
| $624K | ﹤0.01% |
13,500
+3,300
| +32% | +$153K |
|
|
CBM
2004
DELISTED
Cambrex Corporation
CBM
| $623K | ﹤0.01% |
33,000
+7,800
| +31% | +$147K |
|
2005
Cass Information Systems
CASS
$565M
| $619K | ﹤0.01% |
15,840
+3,300
| +26% | +$129K |
|
|
SPPI
2006
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $619K | ﹤0.01% |
78,900
+16,200
| +26% | +$127K |
|
2007
OraSure Technologies
OSUR
$242M
| $617K | ﹤0.01% |
77,400
+14,900
| +24% | +$119K |
|
2008
Tredegar Corp
TG
$279M
| $617K | ﹤0.01% |
26,800
+5,700
| +27% | +$131K |
|
|
TSRO
2009
DELISTED
TESARO, Inc.
TSRO
| $616K | ﹤0.01% |
20,900
+8,000
| +62% | +$236K |
|
2010
Select Medical
SEM
$1.55B
| $615K | ﹤0.01% |
91,686
+27,468
| +43% | +$184K |
|
|
MGI
2011
DELISTED
MoneyGram International, Inc. New
MGI
| $615K | ﹤0.01% |
34,870
+11,570
| +50% | +$204K |
|
|
GTY
2012
Getty Realty Corp
GTY
$1.6B
| $614K | ﹤0.01% |
32,914
+6,886
| +26% | +$128K |
|
|
CQB
2013
DELISTED
CHIQUITA BRANDS INTL (NEW)
CQB
| $614K | ﹤0.01% |
49,300
+10,400
| +27% | +$130K |
|
2014
Ezcorp Inc
EZPW
$1.04B
| $613K | ﹤0.01% |
56,800
+13,100
| +30% | +$141K |
|
|
AMTG
2015
DELISTED
APOLLO RESIDENTIAL MTG INC COM STK
AMTG
| $612K | ﹤0.01% |
37,700
+7,200
| +24% | +$117K |
|
2016
Marten Transport
MRTN
$953M
| $610K | ﹤0.01% |
70,875
+15,750
| +29% | +$136K |
|
2017
Employers Holdings
EIG
$983M
| $609K | ﹤0.01% |
30,100
+7,600
| +34% | +$154K |
|
2018
Hovnanian Enterprises
HOV
$895M
| $609K | ﹤0.01% |
5,148
+1,136
| +28% | +$134K |
|
|
IO
2019
DELISTED
ION Geophysical Corporation
IO
| $609K | ﹤0.01% |
9,640
+2,407
| +33% | +$152K |
|
2020
Strategic Education
STRA
$1.98B
| $608K | ﹤0.01% |
13,100
+2,700
| +26% | +$125K |
|
|
KBAL
2021
DELISTED
Kimball International
KBAL
| $608K | ﹤0.01% |
43,042
+7,430
| +21% | +$105K |
|
|
CNR
2022
DELISTED
Cornerstone Building Brands, Inc.
CNR
| $608K | ﹤0.01% |
34,800
+12,600
| +57% | +$220K |
|
|
AAIC
2023
DELISTED
Arlington Asset Investment Corp.
AAIC
| $606K | ﹤0.01% |
22,900
+4,900
| +27% | +$130K |
|
|
VWTR
2024
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
| $606K | ﹤0.01% |
23,300
+5,000
| +27% | +$130K |
|
2025
Anika Therapeutics
ANIK
$125M
| $604K | ﹤0.01% |
14,700
+3,400
| +30% | +$140K |
|